24/7 Market News – (NASDAQ:IKNA) shares are moving higher this morning on FDA fast track news.

$3.53 shares are up 1% pre market with over 5303 trades.

Ikena Oncology Receives FDA Fast Track Designation for Novel TEAD Inhibitor IK-930 to Treat Unresectable NF2-Deficient Mesothelioma

https://www.nasdaq.com/press-release/ikena-oncology-receives-fda-fast-track-designation-for-novel-tead-inhibitor-ik-930-to

RelatedNews

Signup today for free and be the first to get notified of breaking news.

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist